1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional) is sponsored by NIH Fogarty International Center (FIC). This NOFO encourages exploratory/developmental research applications to study the development, validation, feasibility, and effectiveness of innovative mobile health (mHealth) interventions or tools specifically suited for low- and middle-income countries (LMICs).
The overall goal is to catalyze innovation through multidisciplinary research that addresses global health problems and strengthens mHealth research capacity in LMICs. Applicants must address both the R21 and R33 phases and propose partnerships between at least one U.S. institution and one LMIC institution.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: U.S. institutions and LMIC institutions in partnership. Higher Education Institutions are always encouraged to apply for NIH support. Confirm the full requirements in the official notice before applying.
The current listing shows R21 phase: up to $125,000 in direct costs per year; R33 phase: up to $200,000 in direct costs per year. Total project period may not exceed 5 years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional) is funded by NIH Fogarty International Center (FIC). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
RFA-OD-27-009 puts $20 million behind five commercialization hubs, closing November 10, 2026. Prior REACH and NCAI recipients are explicitly ineligible, the applicant must have been an STTR partner, and the old 1:1 match is now $250,000 that is encouraged but not scored.
Read articleThe All of Us X01 is a Resource Access Award, not a funding award. It conveys serum, plasma and genomic DNA from a 613,000-participant biobank, requires you to prove you already have the money, and gives you nine months of exclusivity before your own assay data goes public.
Read articleOLAW's new RFI asks whether institutions can report annual live vertebrate animal numbers with USDA pain and distress categories for species the Animal Welfare Act does not cover. Comments close December 21, 2026. The burden falls on the 90 percent of research animals nobody currently counts.
Read article